Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Determinants of retinoid X receptor transcriptional antagonism.

Cavasotto CN, Liu G, James SY, Hobbs PD, Peterson VJ, Bhattacharya AA, Kolluri SK, Zhang XK, Leid M, Abagyan R, Liddington RC, Dawson MI.

J Med Chem. 2004 Aug 26;47(18):4360-72.

PMID:
15317450
3.

[Retinoid antagonists].

Umemiya H, Kagechika H, Fukasawa H, Hashimoto Y, Shudo K.

Yakugaku Zasshi. 1996 Dec;116(12):928-41. Review. Japanese.

PMID:
8993231
4.

Linkage between retinoid and fatty acid receptors: implications for breast cancer prevention.

Stoll BA.

Eur J Cancer Prev. 2002 Aug;11(4):319-25. Review.

PMID:
12195157
5.

Design of selective nuclear receptor modulators: RAR and RXR as a case study.

de Lera AR, Bourguet W, Altucci L, Gronemeyer H.

Nat Rev Drug Discov. 2007 Oct;6(10):811-20. Review.

PMID:
17906643
6.

Recent developments in receptor-selective retinoids.

Nagpal S, Chandraratna RA.

Curr Pharm Des. 2000 Jun;6(9):919-31. Review.

PMID:
10828316
7.

RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases.

van Neerven S, Kampmann E, Mey J.

Prog Neurobiol. 2008 Aug;85(4):433-51. doi: 10.1016/j.pneurobio.2008.04.006. Epub 2008 May 4. Review.

PMID:
18554773
8.

Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.

Lefebvre P.

Curr Drug Targets Immune Endocr Metabol Disord. 2001 Aug;1(2):153-64. Review.

PMID:
12476796
9.

Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex.

Ziouzenkova O, Plutzky J.

FEBS Lett. 2008 Jan 9;582(1):32-8. Epub 2007 Dec 7. Review.

10.

Retinoids and receptor interacting protein 140 (RIP140) in gene regulation.

Wei LN.

Curr Med Chem. 2004 Jun;11(12):1527-32. Review.

PMID:
15180561
11.

RAR and RXR modulation in cancer and metabolic disease.

Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H.

Nat Rev Drug Discov. 2007 Oct;6(10):793-810. Review.

PMID:
17906642
13.

Novel synthetic retinoids and separation of the pleiotropic retinoidal activities.

Kagechika H.

Curr Med Chem. 2002 Mar;9(5):591-608. Review.

PMID:
11945126
14.

Synthetic retinoids and their nuclear receptors.

Dawson MI.

Curr Med Chem Anticancer Agents. 2004 May;4(3):199-230. Review.

PMID:
15134501
15.

Is 9-cis-retinoic acid the endogenous ligand for the retinoic acid-X receptor?

Wolf G.

Nutr Rev. 2006 Dec;64(12):532-8. Review.

PMID:
17274495
16.

Regulation of lipid and lipoprotein metabolism by retinoids.

Staels B.

J Am Acad Dermatol. 2001 Nov;45(5):S158-67. Review.

PMID:
11606948
17.

Nuclear retinoid receptors and the transcription of retinoid-target genes.

Bastien J, Rochette-Egly C.

Gene. 2004 Mar 17;328:1-16. Review.

PMID:
15019979
18.

Retinoic acid receptor modulators: a perspective on recent advances and promises.

Alvarez S, Bourguet W, Gronemeyer H, de Lera AR.

Expert Opin Ther Pat. 2011 Jan;21(1):55-63. doi: 10.1517/13543776.2011.536531. Epub 2010 Nov 20. Review.

PMID:
21091043
19.

Selective RXR modulators for the treatment of type II diabetes.

Faul MM, Grese TA.

Curr Opin Drug Discov Devel. 2002 Nov;5(6):974-85. Review.

PMID:
12478728
20.

[From cancer prevention to cancer treatment].

Shudo K.

Yakugaku Zasshi. 2000 Oct;120(10):987-95. Review. Japanese.

PMID:
11082709
Items per page

Supplemental Content

Write to the Help Desk